Companies: 10,795·Total market cap: $144.5T

ConvaTec Group Plc

ConvaTec Group Plc

CNVVFOTCHealthcare● Active

$2.62

+$0.32(+13.91%)

Market Cap$5.1B

P/E Ratio—

52W High$3.95

52W Low$2.3

Avg Volume492

Open$2.62

Beta0.76

股票排行：Medical - Instruments & Supplies·Healthcare·查看全部市值排行 →

ConvaTec Group Plc（CNVVF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CNVVF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$0.18Earnings history

PE Ratio (TTM)14.7×PE Ratio deep dive

Revenue (TTM)$4.7BFull revenue history

Dividend Yield2.25%Dividend history

Shares Outstanding2.02BShares outstanding history

Next EarningsAug 4, 2026Est.Earnings history

探索 ConvaTec Group Plc 数据

分析师预测—

营收$2.5B+8.91%

盈利EPS $0.09-4.95%

市盈率14.7×

财务快照

FY 2025Revenue$2.49B▲ +8.91% YoY

202320242025

FY 2025Net Income$178.9M▼ 6.09% YoY

202320242025

FY 2025EPS$0.09▼ 4.95% YoY

202320242025

TTM:Revenue: $4.70BNet Income: $362.5MEPS: $0.18View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

ConvaTec Group Plc

$2.62+13.91%$5.1B #2

DiaSorin S.p.A.

$84.10+0.00%$4.5B #3

$52.85+4.14%$4.4B #4

$10.13+1.96%$4.3B #5

Getinge AB (publ)

$20.15-1.37%$5.5B #6

Raia Drogasil S.A.

$3.52+2.33%$6.2B

股票表现

1D+13.91%

1W+13.91%

1M-12.37%

3M-22.94%

YTD-10.58%

1Y-27.22%

5Y-19.38%

关于 ConvaTec Group Plc

CEOJonathan Peter Mason

IPO DateMar 7, 2017

Employees10,489

CountryGB

Websiteconvatecgroup.com

ConvaTec Group Plc is a global medical technology company focused on creating, producing, and distributing a wide array of healthcare products. Their offerings span several key areas: Advanced Wound M…

Medical - Instruments & Supplies HealthcareOTCGB

关于股票概览与关键数据

ConvaTec Group Plc（CNVVF）是 Medical - Instruments & Supplies 行业的 Healthcare 类公司，于 Mar 7, 2017 在 OTC 上市。截至最近交易日，CNVVF 股价为 $2.62，市值约为 $5.1B。过去12个月累计回报 -27.22%，年初至今回报 -10.58%。

2025 财年 ConvaTec Group Plc 营收 $2.5B。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，ConvaTec Group Plc（CNVVF）股价为 $2.62，在 OTC 上市，52周区间为 $2.30 – $3.95。

CNVVF 最新股价CNVVF quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议